Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.03 (-3.33%)
Close on Nov 13, 2026Market cap $14.51MP/E –Yield –
Marker Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Marker Therapeutics's profit margin for the twelve months ending Mar 31, 2026 was -275.9%. For fiscal 2025 it was -343.0%, against -162.8% the year before. The highest annual figure on record is -162.8% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -343.0% | −180.1 |
| FY2024 | Dec 31, 2024 | -162.8% | +85.9 |
| FY2023 | Dec 31, 2023 | -248.8% | +603.1 |
| FY2022 | Dec 31, 2022 | -851.9% | +2520.8 |
| FY2021 | Dec 31, 2021 | -3372.7% | +2368.5 |
| FY2020 | Dec 31, 2020 | -5741.2% | +4309.7 |
| FY2019 | Dec 31, 2019 | -10050.9% | +61775.4 |
| FY2018 | Dec 31, 2018 | -71826.3% | −65827.2 |
| FY2017 | Dec 31, 2017 | -5999.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -423.0% | +850.6 |
| Q4 FY2025 | Dec 31, 2025 | -154.4% | +16.1 |
| Q3 FY2025 | Sep 30, 2025 | -162.1% | −42.3 |
| Q2 FY2025 | Jun 30, 2025 | -466.3% | −278.8 |
| Q1 FY2025 | Mar 31, 2025 | -1273.6% | −1081.3 |
| Q4 FY2024 | Dec 31, 2024 | -170.4% | +94.9 |
| Q3 FY2024 | Sep 30, 2024 | -119.8% | +1037.7 |
| Q2 FY2024 | Jun 30, 2024 | -187.5% | −517.4 |
| Q1 FY2024 | Mar 31, 2024 | -192.3% | +210.1 |
| Q4 FY2023 | Dec 31, 2023 | -265.3% | +242.7 |
| Q3 FY2023 | Sep 30, 2023 | -1157.6% | −465.3 |
| Q2 FY2023 | Jun 30, 2023 | 329.9% | +1499.3 |
| Q1 FY2023 | Mar 31, 2023 | -402.4% | +625.3 |
| Q4 FY2022 | Dec 31, 2022 | -508.0% | +25104.6 |
| Q3 FY2022 | Sep 30, 2022 | -692.3% | +666.3 |
| Q2 FY2022 | Jun 30, 2022 | -1169.4% | +1213.0 |
| Q1 FY2022 | Mar 31, 2022 | -1027.7% | +1308.7 |
| Q4 FY2020 | Dec 31, 2020 | -25612.6% | −23435.5 |
| Q2 FY2020 | Jun 30, 2020 | -1358.6% | – |
| Q4 FY2019 | Dec 31, 2019 | -2382.4% | – |
| Q2 FY2018 | Jun 30, 2018 | -2336.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -2177.1% | – |
See a number that looks wrong?